Home
    • Plans Blog Contact
    iANTHUS CAPITAL HOLDINGS, INC. logo

    iANTHUS CAPITAL HOLDINGS, INC.

    ITHUF
    Last price US$0.0042
    Market cap US$27.9m
    12M price change -17.65%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Zoetis IncZTS Industry peer Amphastar PAMPH Industry peer Prestige Consumer HealthcarePBH Industry peer IQVIA Holdings IncIQV Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    iANTHUS CAPITAL HOLDINGS, INC. Overview

    Industry: Drug Manufacturers Specialty & Generic

    Sector: Healthcare

    iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. iAnthus Capital Holdings, Inc. was founded in 2014 and is headquartered in New York, New York. iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for iANTHUS CAPITAL HOLDINGS, INC. into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed May 12, 2026

    Quarterly result summary

    Revenue was $33.5M (reported). Net loss was -$14.3M. Net income was -$14.1M (-374% YoY).

    Revenue $33.5M reported
    Net loss -$14.3M reported
    Net income -$14.1M -374% YoY
    Adjusted EBITDA $5.4M reported

    What changed

    • Revenue reported to $33.5M.
    • Net income -374% YoY to -$14.1M.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 8-K May 12, 2026 SEC filing 10-Q May 12, 2026 Earnings release Earnings release Mar 27, 2026 SEC filing 8-K Mar 27, 2026 SEC filing 10-K Mar 27, 2026 SEC filing 10-Q Nov 12, 2025 SEC filing 10-Q Aug 12, 2025 Earnings release Earnings release Aug 12, 2025 SEC filing 8-K Aug 12, 2025 SEC filing 10-Q May 12, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    No qualified company news in the last 14 days

    No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.

    Earnings Per Share

    Score 4.00/5
    iANTHUS CAPITAL HOLDINGS, INC. boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Drug Manufacturers Specialty & Generic industry , Zoetis Inc , Amphastar P , Prestige Consumer Healthcare are companies with high ratings.

    Return on Equity

    Score 2.38/5
    iANTHUS CAPITAL HOLDINGS, INC. exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    iANTHUS CAPI... ITHUF US$27.9m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 1.83/5
    iANTHUS CAPITAL HOLDINGS, INC. olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    iANTHUS CAPI... ITHUF US$27.9m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Drug Manufacturers Specialty & Generic industry , Zoetis Inc , Amphastar P , Prestige Consumer Healthcare are companies with high ratings.

    Leverage

    Score 1.01/5
    iANTHUS CAPITAL HOLDINGS, INC. registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc have achieved high scores.
    iANTHUS CAPI... ITHUF US$27.9m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    iANTHUS CAPITAL HOLDINGS, INC. logo

    iANTHUS CAPITAL HOLDINGS, INC.

    US$0.0042

    US$27.9m

    -10.64%

    -17.65%